JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHULTZ, F. H.
Right arrow Articles by HILL, R. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SCHULTZ, F. H.
Right arrow Articles by HILL, R. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 69, Issue 4, 324-330, 1940
Copyright © 1940 by American Society for Pharmacology and Experimental Therapeutics


THE TOXICITY OF THE SODIUM SALT OF 1,5 DIPHENYLPYRAZOLINE-3-CARBOXYLIC ACID

FRED H. SCHULTZ 1 and ROBERT M. HILL 1

1 From the Department of Biochemistry, University of Colorado School of Medicine, Denver, Colorado

1. The toxicity of 1,5 diphenylpyrazoline-3-carboxylic acid for albino rats has been determined. The LD50 for intraperitoneal administration is between 320 and 340 mgm. per kilogram. The LD50 for oral administration is between 500 and 550 mgm. per kilogram.

2. After oral administration of this pyrazoline derivative, the body temperature fall is greater in those animals that die.

3. After administration of the sodium salt of 1,5 diphenylpyrazoline-3-carboxylic acid the urine, frequently the nasal secretions, and after oral administration, the feces, give positive tests for diphenylpyrazoline compounds.

4. A depressive state which roughly parallels the time of body temperature fall follows the administration of this compound.

5. In from 10 to 25 per cent of the rats, when the dose was 300 mgm. per kilogram or greater, convulsions resembling those after morphine administration followed the intraperitoneal injection of the sodium salt of 1,5 diphenylpyrasoline-3-carboxylic acid. Similar convulsions in about the same proportion of the animals followed the oral administration of this compound when the dose was as large as 500 mgm. per kilogram of body weight.

6. Growth curve experiments show that in doses of about frac13 of the LD50, given twice weekly, there is no cumulative toxic activity of such a nature that the growth rate in young rats is depressed.

Submitted on April 19, 1940







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1940 by the American Society for Pharmacology and Experimental Therapeutics.